Join
Live feed
·
INSIDERFilingvia Quantisnow
PMV Pharmaceuticals Inc. logo

Chief Development Officer Jalota Deepika sold $35,198 worth of shares (33,065 units at $1.06), decreasing direct ownership by 27% to 89,959 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
PMVP· PMV Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PMVP (PMV Pharmaceuticals Inc.) and more on Quantisnow.